Article ; Online: Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.
The American journal of tropical medicine and hygiene
2021 Volume 104, Issue 5, Page(s) 1611–1612
Abstract: COVID-19 can trigger a systemic inflammatory response that in some cases leads to severe lung involvement, multisystem dysfunction, and death. Dexamethasone therapy, because of its potent anti-inflammatory effects, has been proposed for the management of ...
Abstract | COVID-19 can trigger a systemic inflammatory response that in some cases leads to severe lung involvement, multisystem dysfunction, and death. Dexamethasone therapy, because of its potent anti-inflammatory effects, has been proposed for the management of hospitalized patients with severe COVID-19. The subject of this article is to discuss potential strategies to tackle Strongyloides hyperinfection in hospitalized patients with COVID-19 receiving dexamethasone therapy in low- and middle-income countries. In this context, dexamethasone treatment has been found to be generally safe. However, its use in people coinfected with undetected Strongyloides stercoralis increases the risk for Strongyloides hyperinfection/dissemination a potentially fatal complication. Infection caused by S. stercoralis may remain asymptomatic or with mild symptoms in humans for several years. Early detection and specific treatment prevent a fatal evolution of this complication, but the challenge is to screen before corticosteroid therapy. In some cases, presumptive treatment may be justified. Ivermectin is the gold standard for treatment. |
---|---|
MeSH term(s) | Animals ; Developing Countries ; Dexamethasone/adverse effects ; SARS-CoV-2 ; Strongyloides stercoralis ; Strongyloidiasis/drug therapy ; Strongyloidiasis/etiology ; COVID-19 Drug Treatment |
Chemical Substances | Dexamethasone (7S5I7G3JQL) |
Language | English |
Publishing date | 2021-03-15 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2942-7 |
ISSN | 1476-1645 ; 0002-9637 |
ISSN (online) | 1476-1645 |
ISSN | 0002-9637 |
DOI | 10.4269/ajtmh.20-1085 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ud II Zs.61: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.